22nd May 2006
Lawrence plc
ECO receives further drug marketing authorisations
Lawrence plc is pleased to report that its Eco Animal Health (Eco) subsidiary
has received further marketing authorisations for Ecomectin, its veterinary anti-
parasitic endectocide.
These approvals have been received through the European Mutual Recognition
Procedure (MRP) and will now allow Eco to market Ecomectin injection in eleven
key European markets for the treatment of pigs. Ecomectin injection is already
authorised for the treatment of cattle and sheep. A further round of MRP
applications is in process to extend this claim for pigs into additional
important European markets.
Peter Lawrence, Chairman of Lawrence plc commented:
"This further authorisation is another important and valuable step for Eco. It
will enable us to extend our sales effort by providing new applications within
the fast growing European market for animal health products"
Contacts:
Peter Lawrence
Chairman, Lawrence plc
020 8336 2900
Anthony Spiro
Spiro Financial
020 8336 6196
Philip Davies
Charles Stanley Securities
020 7953 2457
Note to Editors:
Lawrence plc is a leader in the development, manufacture and distribution of
principally specialist chemical and pharmaceutical products for the animal
health and farming markets worldwide. Our products for these growth markets
incorporate natural ingredients to promote well-being and sustainability. We
achieve our financial goals through the careful and responsible application of
science to generate value for our shareholders.